Kopp Investment Advisors’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

Kopp Investment Advisors’s Portfolio PTX Stock Details PTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-31,529	Closed	-$931K	–	71
2015 Q4	$931K	Sell	31,529 -6,000	-16%	-$181K	0.46%	36
2015 Q3	$1.19M	Sell	37,529 -1,271	-3%	-$60.8K	0.64%	27
2015 Q2	$2.3M	Sell	38,800 -33,255	-46%	-$2.35M	1.02%	27
2015 Q1	$7.7M	Sell	72,055 -3,768	-5%	-$359K	3.41%	7
2014 Q4	$7.12M	Sell	75,823 -3,643	-5%	-$348K	3.42%	8
2014 Q3	$6.1M	Buy	79,466 +15,991	+25%	+$1.26M	3.02%	12
2014 Q2	$5.7M	Buy	+63,475	New	+$3.89M	2.62%	11

Other funds holding PTX

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

ECP

Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Kopp Investment Advisors's PTX Position: Q1 2016 in Review

Kopp Investment Advisors sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q1 2016, closing a stake of 31,529 shares — an estimated $931K sold.

Kopp Investment Advisors first reported a position in PTX in Q2 2014 and held it in 7 quarters. The position peaked at $7.7M in Q1 2015. 88 funds tracked by Wall St. Rank hold PTX as of Q1 2016.

Kopp Investment Advisors reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q1 2016 after selling out during the quarter.
Kopp Investment Advisors sold 31,529 Pernix Therapeutics Holdings, Inc. shares in Q1 2016, an estimated $931K.
Kopp Investment Advisors first reported a position in Pernix Therapeutics Holdings, Inc. in Q2 2014 and held it in 7 quarters.
Kopp Investment Advisors's Pernix Therapeutics Holdings, Inc. position peaked at $7.7M in Q1 2015.
88 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q1 2016.

Based on Kopp Investment Advisors's 13F filing for Q1 2016, filed 16 May 2016.